Search

Search Constraints

You searched for: Author/Creator Santinami, Mario

Search Results

1. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial. Issue 3 (March 2020)

2. Association of promoter polymorphism −765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts. Issue 10 (October 2014)

3. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients. Issue 6 (27th May 2013)

4. Clinical and immunologic responses in melanoma patients vaccinated with MAGE‐A3‐genetically modified lymphocytes. Issue 11 (13th December 2012)

5. Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta‐analysis. (7th November 2022)

6. Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30–39]. (November 2020)

7. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Issue 7 (6th July 2022)

10. Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells. (28th June 2016)